Detalhe da pesquisa
1.
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Blood
; 142(6): 553-560, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257195
2.
Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
Br J Haematol
; 201(6): 1097-1102, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921595
3.
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
Haematologica
; 108(12): 3347-3358, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139600
4.
Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
Br J Haematol
; 199(3): 382-391, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880396
5.
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group.
Br J Haematol
; 196(1): 99-104, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396513
6.
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Br J Haematol
; 196(1): 116-126, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520052
7.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol
; 196(3): 606-616, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775591
8.
How I treat nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 136(26): 2987-2993, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877522
9.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Blood
; 136(25): 2851-2863, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113552
10.
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
BMC Cancer
; 22(1): 672, 2022 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717166
11.
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Eur J Haematol
; 109(6): 728-735, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056778
12.
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Infection
; 50(4): 925-932, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182355
13.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
14.
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Br J Haematol
; 193(3): 515-519, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486762
15.
Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma.
Curr Opin Oncol
; 33(5): 395-399, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224482
16.
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP.
Haematologica
; 106(6): 1684-1692, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381573
17.
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
Blood
; 131(15): 1666-1678, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500174
18.
Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.
Blood
; 132(14): 1519-1525, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064977
19.
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
Blood
; 132(21): 2273-2279, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30166329
20.
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.
Blood
; 132(19): 2040-2052, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194254